Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Camila Fabiani"'
Autor:
Camila Fabiani, Silvia S. Antollini
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Biological membranes show lateral and transverse asymmetric lipid distribution. Cholesterol (Chol) localizes in both hemilayers, but in the external one it is mostly condensed in lipid-ordered microdomains (raft domains), together with saturated phos
Externí odkaz:
https://doaj.org/article/005ae5cf88e04f64bdff5f3f970373e7
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Amyloid β peptide (Aβ) is a key player in the development of Alzheimer’s disease (AD). It is the primary component of senile plaques in AD patients and is also found in soluble forms. Cholinergic activity mediated by α7 nicotinic receptors has b
Externí odkaz:
https://doaj.org/article/faa539a03957486bac9f907562deddfc
Autor:
Albano Mazzarini Dimarco, Camila Fabiani, Jeremias Corradi, Cecilia Bouzat, Noelia Rodriguez Araujo
Publikováno v:
Biophysical Journal. 119:1670-1682
The serotonin type 3 receptor (5-HT 3) is a ligand-gated ion channel that converts the binding of the neurotransmitter serotonin (5-HT) into a transient cation current that mediates fast excitatory responses in peripheral and central nervous systems.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08413fa4b078cc6e86a7ce5b0fc107af
https://doi.org/10.1016/j.bpj.2020.08.029
https://doi.org/10.1016/j.bpj.2020.08.029
Autor:
Noelia, Rodriguez Araujo, Camila, Fabiani, Albano, Mazzarini Dimarco, Cecilia, Bouzat, Jeremías, Corradi
Publikováno v:
Biophys J
The serotonin type 3 receptor (5-HT(3)) is a ligand-gated ion channel that converts the binding of the neurotransmitter serotonin (5-HT) into a transient cation current that mediates fast excitatory responses in peripheral and central nervous systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::411a8bc781bb1559070faceb0890a768
https://pubmed.ncbi.nlm.nih.gov/32946769
https://pubmed.ncbi.nlm.nih.gov/32946769
Publikováno v:
Neuropharmacology. 135:464-473
Cholinergic deficit is regarded as an important factor responsible for Alzheimer's disease (AD) symptoms. Acetylcholinesterase (AChE) and nicotinic receptor (AChR) are two molecular targets for the treatment of this disease. We found here that methan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d051198c63d160186d6757fae69d0d
https://doi.org/10.1016/j.neuropharm.2018.03.041
https://doi.org/10.1016/j.neuropharm.2018.03.041
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Cellular Neuroscience
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Frontiers in Cellular Neuroscience
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Amyloid β peptide (Aβ) is a key player in the development of Alzheimer’s disease (AD). It is the primary component of senile plaques in AD patients and is also found in soluble forms. Cholinergic activity mediated by α7 nicotinic receptors has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d48034b256ab9388c8b3933cd4c61ff
https://www.frontiersin.org/articles/10.3389/fncel.2019.00037/full
https://www.frontiersin.org/articles/10.3389/fncel.2019.00037/full
